Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Summary of the probe development efforts to identify antagonists of the vasopressin 1a receptor (V1a-R)
SummaryPubMed CitationRelated BioAssays by DepositorRelated BioAssays by Same ProjectRelated BioAssays by Target
Late-stage results from the probe development effort to identify antagonists of arginine vasopressin receptor 1a (AVPR1a): luminescence-based cell-based dose response counterscreen assay to determine cytotoxicity of the test compound
Assay data:1 Tested
SummaryPubMed CitationRelated BioAssays by DepositorRelated BioAssays by Same Project
Late-stage counterscreen panel assay for AVPR1a antagonists: Panlabs HitProfilingScreen
Assay data:1 Active, 1 Tested
SummaryCompounds, ActivePubMed CitationRelated BioAssays by DepositorRelated BioAssays by Same ProjectRelated BioAssays by Target
Late-stage results from the probe development effort to identify antagonists of arginine vasopressin receptor 1a (AVPR1a): fluorescence-based cell-based dose response AVPR2 inhibition counterscreen assay
Assay data:9 Active, 31 Tested
Late-stage results from the probe development effort to identify antagonists of arginine vasopressin receptor 1a (AVPR1a): fluorescence-based cell-based dose response AVPR1a inhibition assay
Assay data:31 Active, 30 Activity ≤ 1 µM, 31 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by DepositorRelated BioAssays by Same ProjectRelated BioAssays by Target
Late-stage results from the probe development effort to identify antagonists of arginine vasopressin receptor 1a (AVPR1a): fluorescence-based cell-based dose response AVPR1b inhibition counterscreen assay
Assay data:6 Active, 31 Tested
Late-stage results from the probe development effort to identify antagonists of arginine vasopressin receptor 1a (AVPR1a): fluorescence-based cell-based dose response OXTR inhibition counterscreen assay
Assay data:19 Active, 9 Activity ≤ 1 µM, 31 Tested
Late-stage results from the probe development effort to identify antagonists of vasopressin receptor 1a (V1a-R): LCMS-based biochemical hepatic microsome stability assay
Late-stage results from the probe development effort to identify antagonists of vasopressin receptor 1a (V1a-R): LCMS-based in vivo plasma and brain levels
Late-stage results from the probe development effort to identify antagonists of vasopressin receptor 1a (V1a-R): LCMS-based pharmacokinetic plasma protein and brain tissue binding assay
SummaryCompounds, ActivePubMed CitationRelated BioAssays by DepositorRelated BioAssays by Same Project
Late-stage results from the probe development effort to identify antagonists of vasopressin receptor 1a (V1a-R): LCMS-based biochemical cytochrome P450 inhibition assay
Late-stage results from the probe development effort to identify antagonists of vasopressin receptor 1a (V1a-R): LCMS-based PK parameters
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on